Masayo Kotaka

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The immunosuppressive drug FK506 reveals an anti-malarial activity. The mechanism of the drug action involves the molecular interaction with target proteins PfFKBP35 and PvFKBP35 from P. falciparum and P. vivax, respectively. Interestingly, non-immunosup-pressive FK506 analogues also show antimalarial activities. This prompted us to attempt to develop(More)
  • 1